Drawing for AQC

USPTO serial 87336824

AQC

Reviewed by CopyMark Law Group

Reg. 5421474Status 702Registered
Filing date
Status date
Registration date
Mar 13, 2018
Examiner
BEDNARZ, DUSTIN THOMAS
Law office
FILE DESTROYED

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with AQC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica L. Rothstein

Jessica L. Rothstein Goodwin Procter LLP620 Eighth AvenueNew York, NY 10018United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, providing information management services; formulation of best practices for clinical trial execution and management for the testing of drugs, biologics, and medical devices; preparation of business reports related to key trends and innovations in clinical trial execution and management for the testing of drugs, biologics, and medical devices; conducting conferences in the fields of clinical trials for the testing of drugs, biologics, and medical devices for business purposesACTIVE—
041Conducting seminars in the fields of clinical trials for the testing of drugs, biologics, and medical devices; conducting educational programs, presentations, conferences and seminars in the fields of clinical trials for the testing of drugs, biologics, and medical devicesACTIVE—
042Technical consulting in the field of clinical trials for the testing of drugs, biologics, and medical devices; consulting services in the fields of research and development for drugs, biologics, and medical devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 17, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 17, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 11, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Mar 13, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 9, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 9, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 9, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 9, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 9, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 25, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 16, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 11, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 11, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 11, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 11, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 13, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 24, 2018DOCKASSIGNED TO EXAMINER—
Jan 24, 2018DOCKASSIGNED TO EXAMINER—
Dec 26, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 26, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 6, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 13, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 2, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 1, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 21, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 31, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2017DOCKASSIGNED TO EXAMINER—
Feb 22, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance